A detailed history of Morgan Stanley transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,198,165 shares of CRBU stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,198,165
Previous 618,487 93.73%
Holding current value
$2.02 Million
Previous $1.01 Million 130.37%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.56 - $2.73 $904,297 - $1.58 Million
579,678 Added 93.73%
1,198,165 $2.34 Million
Q2 2024

Oct 17, 2024

BUY
$1.62 - $5.05 $330,463 - $1.03 Million
203,990 Added 49.21%
618,487 $1.01 Million
Q2 2024

Aug 14, 2024

BUY
$1.62 - $5.05 $330,463 - $1.03 Million
203,990 Added 49.21%
618,487 $1.01 Million
Q1 2024

Oct 17, 2024

SELL
$4.82 - $8.26 $983,231 - $1.68 Million
-203,990 Reduced 32.98%
414,497 $2.13 Million
Q1 2024

Aug 16, 2024

SELL
$4.82 - $8.26 $3.33 Million - $5.7 Million
-690,316 Reduced 62.48%
414,497 $2.13 Million
Q1 2024

May 15, 2024

SELL
$4.82 - $8.26 $3.33 Million - $5.7 Million
-690,316 Reduced 62.48%
414,497 $2.13 Million
Q4 2023

Aug 16, 2024

BUY
$3.58 - $6.25 $1.74 Million - $3.04 Million
486,326 Added 78.63%
1,104,813 $6.33 Million
Q4 2023

Feb 13, 2024

SELL
$3.58 - $6.25 $2.55 Million - $4.46 Million
-712,866 Reduced 39.22%
1,104,813 $6.33 Million
Q3 2023

Nov 15, 2023

BUY
$4.08 - $8.14 $2.25 Million - $4.48 Million
550,946 Added 43.49%
1,817,679 $8.69 Million
Q2 2023

Aug 14, 2023

BUY
$4.04 - $5.47 $70,639 - $95,642
17,485 Added 1.4%
1,266,733 $5.38 Million
Q1 2023

May 15, 2023

BUY
$4.3 - $7.78 $86,348 - $156,230
20,081 Added 1.63%
1,249,248 $6.63 Million
Q4 2022

Feb 14, 2023

BUY
$5.57 - $11.01 $81,182 - $160,470
14,575 Added 1.2%
1,229,167 $7.72 Million
Q3 2022

Nov 14, 2022

BUY
$5.34 - $12.79 $3.05 Million - $7.31 Million
571,409 Added 88.84%
1,214,592 $12.8 Million
Q2 2022

Oct 27, 2022

BUY
$5.1 - $9.74 $2.25 Million - $4.29 Million
440,295 Added 217.01%
643,183 $3.49 Million
Q2 2022

Aug 15, 2022

BUY
$5.1 - $9.74 $2.25 Million - $4.29 Million
440,295 Added 217.01%
643,183 $3.49 Million
Q1 2022

Oct 27, 2022

SELL
$8.42 - $15.32 $3.71 Million - $6.75 Million
-440,295 Reduced 68.46%
202,888 $1.86 Million
Q1 2022

May 13, 2022

BUY
$8.42 - $15.32 $840,484 - $1.53 Million
99,820 Added 96.85%
202,888 $1.86 Million
Q4 2021

Feb 14, 2022

BUY
$14.59 - $23.26 $734,052 - $1.17 Million
50,312 Added 95.37%
103,068 $1.56 Million
Q3 2021

Nov 15, 2021

BUY
$15.75 - $30.29 $830,907 - $1.6 Million
52,756 New
52,756 $1.26 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $103M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.